J.Haines, “Alzheimer Disease: Perspectives from Epidemiology and Genetics,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 694-698.
2.
B. D.Jameset al., “Contribution of Alzheimer's Disease to Mortality in the United States,”Neurology82 (2014): 1045-50.
3.
R. H.Blank, “The Economic and Social Costs of Alzheimer's Disease,” in Social and Public Policy of Alzheimer's Disease in the United States (Singapore: Palgrave Pivot, Springer Nature, 2018): 34-38.
4.
R. A.Johnson and J.Karlawish, “A Review of Ethical Issues in Dementia,”International Psychogeriatrics27, no. 10 (2015): 1635-1647.
5.
See Haines, supra note 1.
6.
J.Mintzer, “Perspective from Clinical Research: Ethical Issues in Alzheimer's Disease Research,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 699-703.
7.
A.Leibing, “Situated Prevention: Framing the ‘New Dementia’,”Journal of Law, Medicine and Ethics46, no. 3 (2018): 704-716.
8.
P.Kontos and A.Gregorovitch, “Integrating Citizenship, Embodiment, and Relationality: Towards a Reconceptualization of Dance and Dementia in Long-Term Care,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 717-723.
9.
R. H.Blank, “Alzheimer's Disease — Perspective from Political Science: Public Policy Issues,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 724-743.
10.
D. S.Davis, “Advance Directives and Alzheimer's Disease,”Journal of Law, Medicine & Ethics46, no. 3 (2018): 744-748.
11.
E.Fuchs, “What the Theater Taught Me about Alzheimer's (or: The Giraffe in the Hallway Problem),”Journal of Law, Medicine & Ethics46, no. 3 (2018): 749-755.
